HB76 expands New Mexico’s newborn screening law to add heart-related testing for infants at higher risk of congenital heart disease. The bill keeps the existing requirement that all newborns receive screening for a list of congenital and genetic conditions, including critical congenital heart disease screening by pulse oximetry before discharge, and adds a new targeted follow-up requirement for echocardiograms and electrocardiograms when certain risk factors are present.
Under the bill, a newborn must receive an echocardiogram and electrocardiogram if there is a family history of congenital heart disease or if either biological parent reports warning signs associated with inherited heart conditions, such as unexplained fainting, exercise-related chest pain or shortness of breath, sudden unexplained death in the family before age 50, or close relatives with pacemakers or implantable defibrillators at a young age. If a birthing facility lacks the equipment or staff to perform those tests, it must refer the infant’s parents for the tests after discharge. The bill also adds definitions for echocardiogram and electrocardiogram to the statute.
Impact
HB76 amends Section 24-1-6 NMSA 1978, New Mexico’s newborn screening statute, by making targeted cardiac diagnostic testing part of the state’s required newborn disease screening framework for higher-risk infants. It would place an additional obligation on hospitals and birthing facilities to identify risk factors, perform or arrange the tests, and provide referrals when on-site testing is unavailable. The bill does not eliminate parental waiver rights for newborn screening generally, but it expands the scope of required heart-related screening and follow-up for infants meeting the bill’s risk criteria.
Sentiment
The available context suggests the bill is framed as a newborn health and early-detection measure, with a preventive public health purpose. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of opposition or support from lawmakers in the materials supplied. The bill’s caption and text indicate a generally pro-screening, pro-early-diagnosis approach aimed at reducing missed congenital heart disease cases in newborns.
Contention
The main policy issue raised by the bill is the added testing and referral burden on hospitals and birthing facilities, especially smaller facilities that may not have echocardiogram or electrocardiogram equipment or staff. Another possible point of contention is the bill’s reliance on parental-reported family history and symptoms to trigger testing, which could raise questions about implementation, accuracy, and cost. No specific opposing or supporting stakeholders are identified in the provided materials, but the affected parties would include newborns, parents, hospitals, birthing centers, and the state health department.